|
|
#1
07-27-2016, 04:02 PM
|
|||
|
|||
GSK chases next biotech asthma drug with $230 million J&J deal
GSK chases next biotech asthma drug with 0 million J&J deal
LONDON (Reuters) - GlaxoSmithKline has bought global rights to an experimental drug from Johnson & Johnson for up to 175 million pounds ($230 million), raising its bet on a new generation of biotech medicines for severe asthma. ??????? ??????: GSK chases next biotech asthma drug with $230 million J&J deal || ??????: ahlam1399 || ??????: اسم منتداك
|
|
|
العرض الشجري